デフォルト表紙
市場調査レポート
商品コード
1596861

ニュートリゲノミクスの市場規模、シェア、成長分析:製品別、技法別、用途別、最終用途別、地域別 - 産業予測、2024年~2031年

Nutrigenomics Market Size, Share, Growth Analysis, By Product, By Technique, By Application, By End Use, By Region -Industry Forecast 2024-2031.


出版日
発行
SkyQuest
ページ情報
英文 209 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.69円
ニュートリゲノミクスの市場規模、シェア、成長分析:製品別、技法別、用途別、最終用途別、地域別 - 産業予測、2024年~2031年
出版日: 2024年11月17日
発行: SkyQuest
ページ情報: 英文 209 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のニュートリゲノミクスの市場規模は、2022年に3億8,620万米ドルとなり、2023年の4億5,379万米ドルから、2031年までには16億4,874万米ドルに成長し、予測期間(2024年~2031年)のCAGRは17.50%で成長する見通しです。

今後数年間、世界のニュートリゲノミクス市場は、慢性疾患の有病率の上昇を主要な要因として成長する見込みです。過去10年間のプロテオミクス、ゲノミクス、メタボロミクスの進歩により、特に糖尿病、がん、肥満のような食事の選択に影響される疾患において、タンパク質経路を分析することで疾患を特定する能力が著しく向上しています。ニュートリゲノミクスは、食品と遺伝子発現の相互作用を探求し、さまざまな食事成分が個人の遺伝子プロファイルをどのように変化させるかについての洞察を提供します。しかし、遺伝子研究や検査を取り巻く政府の規制がニュートリゲノミクス製品やサービスの市場開拓を妨げるという課題にも直面しています。連邦政府、州政府、あるいは地方自治体によって課せられる法律が厳しくなると、遺伝子検査がより面倒なものとなり、臨床管理や研究における採用に影響を及ぼす可能性があります。さらに、消費者直接検査(DTC)に関連する法律が地域によってまちまちであることが、状況をさらに複雑にしており、ニュートリゲノミクスに携わる企業にとって大きな障壁となっています。その結果、市場拡大の大きな可能性がある一方で、規制上のハードルは、革新的なニュートリゲノミクス検査ソリューションを消費者に提供することを目指す企業にとって、考慮すべき重要な要素になると考えられています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要のトレンド分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主要な市場の考察

  • 主要な成功要因
  • 競合の程度
  • 主要な投資機会
  • 市場エコシステム
  • 技術の進歩
  • 規制情勢
  • ケーススタディ分析
  • PESTEL分析
  • 市場の魅力指数
  • 価格分析

世界のニュートリゲノミクス市場規模:製品別・CAGR(2024年~2031年)

  • 市場概要
  • 試薬・キット
  • サービス

世界のニュートリゲノミクス市場規模:技術別・CAGR(2024年~2031年)

  • 市場概要
  • 唾液
  • 頬粘膜スワブ
  • 血液

世界のニュートリゲノミクス市場規模:用途別・CAGR(2024年~2031年)

  • 市場概要
  • 肥満
  • 心血管疾患
  • がん調査
  • その他

世界のニュートリゲノミクス市場規模:最終用途別・CAGR(2024年~2031年)

  • 市場概要
  • 病院・クリニック
  • オンラインプラットフォーム
  • その他

世界のニュートリゲノミクス市場規模・CAGR(2024年~2031年)

  • 北米(製品、技法、用途、最終用途)
    • 米国
    • カナダ
  • 欧州(製品、技法、用途、最終用途)
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋(製品、技法、用途、最終用途)
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ(製品、技法、用途、最終用途)
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(製品、技法、用途、最終用途)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021年~2023年)

主要企業プロファイル

  • Nutrigenomix
  • The Gene Box
  • Metagenics
  • Xcode Life
  • GX Sciences, LLC(Fagron)
  • Cura Integrative Medicine
  • DNAlife
  • Genova Diagnostics(GDX)
  • Holistic Health International, Llc
  • Vitagene
  • Mapmygenome
  • GeneOmbio
  • 23andMe Inc.
  • DNAfit
  • GX Sciences Inc.
  • Amway
  • Herbalife Nutrition Ltd.
  • DSM Nutritional Products
  • Syngene International

結論と提言

目次
Product Code: SQMIG35H2266

Global Nutrigenomics Market size was valued at USD 386.20 million in 2022 and is poised to grow from USD 453.79 million in 2023 to USD 1648.74 million by 2031, growing at a CAGR of 17.50% during the forecast period (2024-2031).

In the coming years, the global nutrigenomics market is poised for growth, largely driven by the rising prevalence of chronic illnesses. The advancements in proteomics, genomics, and metabolomics over the past decade have significantly enhanced the ability to identify diseases by analyzing protein pathways, especially in conditions like diabetes, cancer, and obesity, which are influenced by dietary choices. Nutrigenomics explores the interplay between food and gene expression, offering insights into how various dietary components can modify an individual's genetic profile. However, the market faces challenges from government regulations surrounding genetic research and testing, which can hamper the development of nutrigenomics products and services. Stricter laws imposed by federal, state, or local authorities can make genetic testing more cumbersome, affecting its adoption in clinical management and research. Additionally, the inconsistency of legislation related to direct-to-consumer (DTC) testing in different regions further complicates the landscape, creating a significant barrier for companies engaged in nutrigenomics. As a result, while there is substantial potential for market expansion, regulatory hurdles will be an important factor to consider for businesses aiming to innovate and bring nutrigenomics testing solutions to consumers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nutrigenomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutrigenomics Market Segmental Analysis

Global Nutrigenomics Market is segmented into Product, Technique, Application, End Use, and region. By Product, the market is classified into Reagents & Kits, and Services. Depending on the Technique, it is categorized into Saliva, Buccal Swab, Blood. According to Application, the market is divided into Obesity, Cardiovascular Diseases, Cancer Research, Other. Based on End Use, the market is segmented into Hospitals & Clinics, Online Platforms, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Nutrigenomics Market

The global nutrigenomics market is witnessing significant growth driven by the escalating prevalence of chronic diseases, such as obesity, diabetes, and cardiovascular conditions. As these health issues become more prevalent, there is a growing demand for personalized nutrition that takes individual genetic factors into account. This customization of dietary approaches not only aids in the prevention and management of these ailments but also stimulates increased investments in tailored nutrition strategies. Consequently, the focus on nutrigenomics, which integrates genetic insights into dietary planning, is propelling market expansion and offering innovative solutions for better health outcomes globally.

Restraints in the Global Nutrigenomics Market

The global nutrigenomics market encounters significant challenges due to limited scientific evidence supporting the effectiveness of personalized nutrition interventions. While research in this area has shown potential, there remains a lack of extensive clinical validation and large-scale studies that demonstrate the long-term benefits of these solutions. Consequently, this uncertainty leads to skepticism among health care professionals and hesitance among consumers, ultimately impacting the overall acceptability and adoption of nutrigenomic solutions. The absence of robust data to substantiate claims about personalized nutrition hampers the market's growth and poses a considerable restraint on its development on a global scale.

Market Trends of the Global Nutrigenomics Market

The global nutrigenomics market is experiencing a significant trend towards personalized nutrition, driven by advancements in genetic testing and data analytics. Consumers are increasingly seeking tailored dietary solutions that align with their unique genetic profiles, which results in optimized health outcomes and preventive care. This surge is further amplified by the growing awareness of the relationship between genes, diet, and health, alongside increasing consumer demand for personalized health interventions. As companies innovate to offer customized nutritional plans, the market is poised for robust growth, with a wide range of applications in personal health management, chronic disease prevention, and overall wellness enhancement.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Case Study Analysis
  • PESTEL Analysis
  • Market Attractiveness Index
  • Pricing Analysis

Global Nutrigenomics Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Reagents & Kits
  • Services

Global Nutrigenomics Market Size by Technique & CAGR (2024-2031)

  • Market Overview
  • Saliva
  • Buccal Swab
  • Blood

Global Nutrigenomics Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Obesity
  • Cardiovascular Diseases
  • Cancer Research
  • Others

Global Nutrigenomics Market Size by End Use & CAGR (2024-2031)

  • Market Overview
  • Hospitals & Clinics
  • Online Platforms
  • Others

Global Nutrigenomics Market Size & CAGR (2024-2031)

  • North America, (Product, Technique, Application, End Use)
    • US
    • Canada
  • Europe, (Product, Technique, Application, End Use)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Technique, Application, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Technique, Application, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Technique, Application, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Nutrigenomix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Gene Box
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metagenics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xcode Life
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GX Sciences, LLC (Fagron)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cura Integrative Medicine
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DNAlife
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genova Diagnostics (GDX)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Holistic Health International, Llc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitagene
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mapmygenome
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeneOmbio
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 23andMe Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DNAfit
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GX Sciences Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amway
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Herbalife Nutrition Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DSM Nutritional Products
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syngene International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation